Serra Veterinary Hospital, Inc.,in conjunction with Stemlogix, is now able to offer regenerative cell therapy with adult stem cell treatment for canine osteoarthritis. Serra Veterinary Hospital, Inc is one of a few locations that are currently approved by Stemlogix to provide this treatment for canines. The stem cells are harvested from fat cells collected from the canine patient to be treated. This does require a minor surgical procedure to collect a minimum of 15-30 grams of the patient’s fat. Once the fat is collected, stem cell production and injection can be done within 90 minutes in the clinic during one office visit.
Stemlogix has been treating horses with fat derived stem cells since 2003, and began conducting clinical studies on dogs in 2005. Initial studies indicate treatment with stem cells decrease pain, and improve mobility and joint range of motion (ROM). Results from treatment of canine patients with arthritis are similar to results reported by Veterinarians that have treated hundreds of equine joints. The risk of adverse reaction is very low since the cells are the animals own. No adverse reactions have been reported in over 100 dogs treated. In horses no systemic reactions have been reported and < 1% of horses have a local tissue reaction. Duration of effect from a single administration can last from several months to over a year.
Estimated costs for the initial fat harvest, processing and initial injection are $1500.00 - $2200.00; costs can vary depending on the size of the patient and the route of administration. If you are interested in having your pet treated for osteoarthritis with autogenous stem cells please read the additional information below to make sure your pet is a good candidate for this treatment. Because this treatment is more costly than medical management and carries minor risks because of the surgical fat harvest, we want to be sure each patient is a good candidate prior to scheduling an appointment.
If you have more questions after reading this information you can access Stemlogix’s web site atwww.Stemlogix.com. Serra Veterinary Hospital can also provide additional printed information.
PATIENT REQUIREMENTS FOR STEM CELL TREATMENT:
COMMERCIAL USES: Osteoarthritis, Polyarthritis, Fractures, Tendon and Ligament Injuries
Good general health as assessed by your regular veterinarian within the last 6 months. Patient records will be required prior to the initial exam, or your pet’s exam will be rescheduled.
Current laboratory work (within 2-4 weeks of fat harvest) including a CBC, Chemistry Profile, U/A, and T4, and tick titers. If current labs are not provided, these tests will be run at the initial examination.
The diagnosis of osteoarthritis confirmed with radiographs (x-rays). Properly labeled diagnostic radiographs need to be brought to the initial examination.
No other serious diseases present which could increase the patients risk with anesthesia or limit response to treatment.
Consistent labeled use of flea and tick control, or screening for tick borne diseases with tick titers prior to treatment; see above.
These requirements are to insure your pet is safe to undergo the surgical procedure for fat harvest, and maximize potential benefit from the stem cell treatment.
THE FOLLOWING WILL DISQUALIFY YOUR PET FOR TREATMENT:
Major illness such as cancer, poorly regulated diabetes mellitus, or endocrine disease that is not controlled.
Concurrent neurological disease, such as degenerative myelopathy, or intervertebral disc disease (IVDD). Stem cells will have limited benefit on mobility issues that are a result of chronic/reoccurring spinal nerve damage or inflammation such as disc disease. Studies on neurologic diseases indicate diseases such as Degenerative Myelopathy and paralysis from trauma or post laminectomy appear to be responsive to stem cell treatment; however these diseases are not currently avaliable for commercial treatment with stem cells. These patients may qualify for other studies that are ongoing, see information below on Developmental and Compassionate Use Studies.
Patients that have not had regular Veterinary care in the last 6 months
Patients without current vaccinations, vaccine titers, or letters for non vaccination for medical reasons.
Patients that have not consistently used Promeris, Frontline or Advantix, and do not have current tick titers. *
*The clinical signs of tick borne disease, which include Lyme disease,
RockyMountain spotted fever and Ehrlichia, can mimic the signs of osteoarthritis. Patient’s becomes infected through the bite of an immature tick or “Nymph”. Because the Nymph is tiny exposure is usually not detected. Tick borne infections can cause damage to joints including immune mediated polyarthritis, and/or systemic damage to organs such as the liver, heart, central nervous system, and kidneys. This type of infection can easily be mistaken for osteoarthritis, and could reduce or eliminate benefit from stem cell treatment. This type of infection should be treated prior to regenerative therapy. Screening for tick borne disease can be done with a blood sample, which can be drawn at the initial examination.
CANINE STEM AND REGENERATIVE CELL THERAPY PROGRAMS:
Processing ....